Literature DB >> 20514288

Metabolic testing of the first-time calcium oxalate stone former: Is it indicated? No.

Hassan Razvi1.   

Abstract

Entities:  

Year:  2010        PMID: 20514288      PMCID: PMC2874599          DOI: 10.5489/cuaj.10074

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  10 in total

Review 1.  The first kidney stone.

Authors:  J Uribarri; M S Oh; H J Carroll
Journal:  Ann Intern Med       Date:  1989-12-15       Impact factor: 25.391

Review 2.  Evaluation of the recurrent stone former.

Authors:  Paramjit S Chandhoke
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

3.  International comparison of cost effectiveness of medical management strategies for nephrolithiasis.

Authors:  Yair Lotan; Jeffrey A Cadeddu; Margaret S Pearle
Journal:  Urol Res       Date:  2005-05-28

4.  The stone clinic effect in patients with idiopathic calcium urolithiasis.

Authors:  D H Hosking; S B Erickson; C J Van den Berg; D M Wilson; L H Smith
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

Review 5.  The practical evaluation and selective medical management of nephrolithiasis.

Authors:  G M Preminger; C Y Pak
Journal:  Semin Urol       Date:  1985-08

Review 6.  Cost-effectiveness of medical management strategies for nephrolithiasis.

Authors:  Yair Lotan; Jeffrey A Cadeddu; Claus G Roerhborn; Charles Y C Pak; Margaret S Pearle
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

7.  Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.

Authors:  B Ettinger; C Y Pak; J T Citron; C Thomas; B Adams-Huet; A Vangessel
Journal:  J Urol       Date:  1997-12       Impact factor: 7.450

8.  Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.

Authors:  L Borghi; T Meschi; F Amato; A Briganti; A Novarini; A Giannini
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

9.  Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.

Authors:  B Ettinger; J T Citron; B Livermore; L I Dolman
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

10.  When is medical prophylaxis cost-effective for recurrent calcium stones?

Authors:  Paramjit S Chandhoke
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

  10 in total
  1 in total

1.  Approach to the Adult Kidney Stone Former.

Authors:  Naim Maalouf
Journal:  Clin Rev Bone Miner Metab       Date:  2012-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.